Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | LNP@Voriconazole, lipid nanoparticle-encapsulated voriconazole |
| Catalog Number | R-Z0178 |
| Alias | voriconazole lipid nanoparticles |
| Appearance | Light blue or colorless transparent liquid |
| Molecular Formula | N/A |
| Solubility | Soluble in organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | drug delivery system |
| Specification | 10mg:Inquiry 25mg:Inquiry 50mg:Inquiry |
| Description | LNP@Voriconazole is an innovative drug delivery system that encapsulates the anti-Fungi drug voriconazole within lipid nanoparticles (LNP). Voriconazole is a broad-spectrum triazole anti-Fungi drug that can effectively inhibit the biosynthesis of ergosterol on Fungi cell membranes. Its mechanism of action is to inhibit the demethylation of 14-α-lanosterol mediated by Fungi cytochrome P450 enzymes, interfere with the activity of Fungi cell wall synthesis enzymes and cell membrane enzymes, destroy the cell membrane and prevent Fungi growth, thereby targeting a variety of deep Fungi infections. Lipid nanoparticles are composed of a variety of lipids with good biocompatibility. They can effectively protect voriconazole from unnecessary reactions with other substances in complex biological environments and improve its stability. At the same time, LNP can enhance the uptake efficiency of voriconazole by cells and deliver the drug to target cells or tissues more efficiently, which has potential application value in Treatment Fungi infection-related diseases. |